lacosamide ucb
ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptika, - lacosamide ucb är indicerat som monoterapi och som tilläggsbehandling vid behandling av partiella anfall med eller utan sekundär generalisering hos vuxna, ungdomar och barn från 4 års ålder med epilepsi.
lacosamide adroiq
extrovis eu ltd. - lakosamid - epilepsi - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide accord
accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptika, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy• in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide g.l. 50 mg + 100 mg + 150 mg + 200 mg filmdragerad tablett
g.l. pharma gmbh - lakosamid - filmdragerad tablett - 50 mg + 100 mg + 150 mg + 200 mg - lakosamid 200 mg aktiv substans; lakosamid 150 mg aktiv substans; lakosamid 100 mg aktiv substans; lakosamid 50 mg aktiv substans
lacosamide medical valley 10 mg/ml sirap
medical valley invest ab - lakosamid - sirap - 10 mg/ml - metylparahydroxibensoat hjälpämne; glycerol 85% hjälpämne; sorbitol hjälpämne; lakosamid 10 mg aktiv substans
dorzolamide/timolol teva 20 mg/ml + 5 mg/ml ögondroppar, lösning
teva sweden ab - dorzolamidhydroklorid; timololmaleat - Ögondroppar, lösning - 20 mg/ml + 5 mg/ml - mannitol hjälpämne; timololmaleat 6,83 mg aktiv substans; dorzolamidhydroklorid 22,26 mg aktiv substans; bensalkoniumklorid hjälpämne - kombinationer
dorzolamide/timolol teva 20 mg/ml + 5 mg/ml ögondroppar, lösning i endosbehållare
teva sweden ab - dorzolamidhydroklorid; timololmaleat - Ögondroppar, lösning i endosbehållare - 20 mg/ml + 5 mg/ml - mannitol hjälpämne; timololmaleat 6,83 mg aktiv substans; dorzolamidhydroklorid 22,26 mg aktiv substans - kombinationer
lacosamide g.l. 10 mg/ml infusionsvätska, lösning
g.l. pharma gmbh - lakosamid - infusionsvätska, lösning - 10 mg/ml - lakosamid 10 mg aktiv substans
dorzolamide/timolol stada 20 mg/ml + 5 mg/ml ögondroppar, lösning i endosbehållare
stada arzneimittel ag - dorzolamidhydroklorid; timololmaleat - Ögondroppar, lösning i endosbehållare - 20 mg/ml + 5 mg/ml - timololmaleat 6,83 mg aktiv substans; mannitol hjälpämne; dorzolamidhydroklorid 22,26 mg aktiv substans
lacosamide medical valley 150 mg filmdragerad tablett
medical valley invest ab - lakosamid - filmdragerad tablett - 150 mg - lakosamid 150 mg aktiv substans